ZBIO

ZBIO R&D Expense Growth

20.79%Fiscal year

Period ending:

ZBIO FY R&D Growth (YoY)%
ZBIO FY R&D Growth (YoY)148.09%-20.56%
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

ZBIO r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Zenas Biopharma Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
20.7878%
131.7709%
-4.2368%
0%

Compare r&d expense growth

All ZBIO financial metrics · ZBIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.